342 related articles for article (PubMed ID: 29100798)
1. Benzo[c][1,2,5]thiadiazole derivatives: A new class of potent Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors.
Wang WL; Chen XY; Gao Y; Gao LX; Sheng L; Zhu J; Xu L; Ding ZZ; Zhang C; Li JY; Li J; Zhou YB
Bioorg Med Chem Lett; 2017 Dec; 27(23):5154-5157. PubMed ID: 29100798
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of heterocyclic bis-aryl amides as novel Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors.
Satheeshkumar R; Zhu R; Feng B; Huang C; Gao Y; Gao LX; Shen C; Hou TJ; Xu L; Li J; Zhu YL; Zhou YB; Wang WL
Bioorg Med Chem Lett; 2020 Jun; 30(11):127170. PubMed ID: 32273218
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 2,5-diaryl-1,3,4-oxadiazole derivatives as novel Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2) inhibitors.
Meng XD; Gao LX; Wang ZJ; Feng B; Zhang C; Satheeshkumar R; Li J; Zhu YL; Zhou YB; Wang WL
Bioorg Chem; 2021 Nov; 116():105384. PubMed ID: 34601294
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2.
Kostrzewa T; Sahu KK; Gorska-Ponikowska M; Tuszynski JA; Kuban-Jankowska A
Drug Des Devel Ther; 2018; 12():4139-4147. PubMed ID: 30584278
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and in vitro activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity.
Zhang L; Jiang CS; Gao LX; Gong JX; Wang ZH; Li JY; Li J; Li XW; Guo YW
Bioorg Med Chem Lett; 2016 Feb; 26(3):778-781. PubMed ID: 26774579
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds.
Lawrence HR; Pireddu R; Chen L; Luo Y; Sung SS; Szymanski AM; Yip ML; Guida WC; Sebti SM; Wu J; Lawrence NJ
J Med Chem; 2008 Aug; 51(16):4948-56. PubMed ID: 18680359
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors.
Li Y; Yu Y; Jin K; Gao L; Luo T; Sheng L; Shao X; Li J
Bioorg Med Chem Lett; 2014 Sep; 24(17):4125-8. PubMed ID: 25124112
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
Liu P; Du Y; Song L; Shen J; Li Q
Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo.
Grosskopf S; Eckert C; Arkona C; Radetzki S; Böhm K; Heinemann U; Wolber G; von Kries JP; Birchmeier W; Rademann J
ChemMedChem; 2015 May; 10(5):815-26. PubMed ID: 25877780
[TBL] [Abstract][Full Text] [Related]
10. Y-shaped bis-arylethenesulfonic acid esters: Potential potent and membrane permeable protein tyrosine phosphatase 1B inhibitors.
Yang F; Xie F; Zhang Y; Xia Y; Liu W; Jiang F; Lam C; Qiao Y; Xie D; Li J; Fu L
Bioorg Med Chem Lett; 2017 May; 27(10):2166-2170. PubMed ID: 28372909
[TBL] [Abstract][Full Text] [Related]
11. Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives.
Li Y; Lu L; Zhu M; Wang Q; Yuan C; Xing S; Fu X; Mei Y
Biometals; 2011 Dec; 24(6):993-1004. PubMed ID: 21618062
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel N-aryl-ω-(benzoazol-2-yl)-sulfanylalkanamides as dual inhibitors of α-glucosidase and protein tyrosine phosphatase 1B.
Wang MY; Cheng XC; Chen XB; Li Y; Zang LL; Duan YQ; Chen MZ; Yu P; Sun H; Wang RL
Chem Biol Drug Des; 2018 Sep; 92(3):1647-1656. PubMed ID: 29745030
[TBL] [Abstract][Full Text] [Related]
13. Identification of demethylincisterol A
Chen C; Liang F; Chen B; Sun Z; Xue T; Yang R; Luo D
Eur J Pharmacol; 2017 Jan; 795():124-133. PubMed ID: 27939989
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors.
Liu WS; Yang B; Wang RR; Li WY; Ma YC; Zhou L; Du S; Ma Y; Wang RL
Bioorg Chem; 2020 Jul; 100():103875. PubMed ID: 32380342
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 1,3-diphenyl-1H-pyrazole derivatives containing rhodanine-3-alkanoic acid groups as potential PTP1B inhibitors.
Sun L; Wang P; Xu L; Gao L; Li J; Piao H
Bioorg Med Chem Lett; 2019 May; 29(10):1187-1193. PubMed ID: 30910462
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory Activity of Iron Chelators ATA and DFO on MCF-7 Breast Cancer Cells and Phosphatases PTP1B and SHP2.
Kuban-Jankowska A; Sahu KK; Gorska-Ponikowska M; Tuszynski JA; Wozniak M
Anticancer Res; 2017 Sep; 37(9):4799-4806. PubMed ID: 28870898
[TBL] [Abstract][Full Text] [Related]
17. Novel, potent, selective and cellular active ABC type PTP1B inhibitors containing (methanesulfonyl-phenyl-amino)-acetic acid methyl ester phosphotyrosine mimetic.
Liu P; Du Y; Song L; Shen J; Li Q
Bioorg Med Chem; 2015 Nov; 23(21):7079-88. PubMed ID: 26481657
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of several oleanolic acid glycoconjugates as protein tyrosine phosphatase 1B inhibitors.
Liu Q; Guo T; Li D; Li F; Li W
Eur J Med Chem; 2014 May; 79():34-46. PubMed ID: 24721313
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of geniposide derivatives as potent and selective PTPlB inhibitors.
Lei S; Zhang D; Qi Y; Chowdhury SR; Sun R; Wang J; Du Y; Fu L; Jiang F
Eur J Med Chem; 2020 Nov; 205():112508. PubMed ID: 32738350
[TBL] [Abstract][Full Text] [Related]
20. Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells.
Lee YJ; Song H; Yoon YJ; Park SJ; Kim SY; Cho Han D; Kwon BM
Biochem Pharmacol; 2020 May; 175():113920. PubMed ID: 32201212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]